Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ADAM17 anticorps (C-Term)

ADAM17 Reactivité: Humain, Rat, Souris WB, ELISA, FACS, ICC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1030720
  • Antigène Voir toutes ADAM17 Anticorps
    ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
    Épitope
    • 16
    • 13
    • 8
    • 8
    • 7
    • 7
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 109
    • 53
    • 51
    • 4
    • 4
    • 4
    • 1
    • 1
    Humain, Rat, Souris
    Hôte
    • 94
    • 13
    • 2
    • 1
    • 1
    Lapin
    Clonalité
    • 86
    • 25
    Polyclonal
    Conjugué
    • 53
    • 10
    • 7
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ADAM17 est non-conjugé
    Application
    • 81
    • 47
    • 39
    • 15
    • 14
    • 14
    • 11
    • 11
    • 9
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
    Specificité
    80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.
    Purification
    Affinity chromatography purified via peptide column
    Top Product
    Discover our top product ADAM17 Anticorps primaire
  • Indications d'application
    TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
  • McGowan, Mullooly, Caiazza, Sukor, Madden, Maguire, Pierce, McDermott, Crown, ODonovan, Duffy: "ADAM-17: a novel therapeutic target for triple negative breast cancer." dans: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).

  • Antigène
    ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
    Autre désignation
    TACE (ADAM17 Produits)
    Synonymes
    anticorps ADAM18, anticorps CD156B, anticorps CSVP, anticorps NISBD, anticorps TACE, anticorps CD156b, anticorps Tace, anticorps adam17, anticorps si:dkey-81b15.2, anticorps adam18, anticorps cd156b, anticorps csvp, anticorps tace, anticorps fc20b01, anticorps wu:fc20b01, anticorps zgc:63886, anticorps ADAM metallopeptidase domain 17, anticorps a disintegrin and metallopeptidase domain 17, anticorps ADAM metallopeptidase domain 17b, anticorps ADAM metallopeptidase domain 17 L homeolog, anticorps ADAM metallopeptidase domain 17a, anticorps ADAM17, anticorps Adam17, anticorps adam17b, anticorps adam17.L, anticorps adam17a
    Poids moléculaire
    Predicted: 93 kDa
    Pathways
    Signalisation Notch, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
Vous êtes ici:
Support technique